{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:45:56Z","timestamp":1792691156871,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2012HM026"],"award-info":[{"award-number":["ZR2012HM026"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2010HM051"],"award-info":[{"award-number":["ZR2010HM051"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["Z-2016-20-1801"],"award-info":[{"award-number":["Z-2016-20-1801"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071081"],"award-info":[{"award-number":["81071081"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jad.2022.08.026","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T10:22:40Z","timestamp":1660558960000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a\/PI3K\/Akt\/mTOR signaling pathways in differentiated rat pheochromocytoma cells"],"prefix":"10.1016","volume":"316","author":[{"given":"Liying","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoming","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nianming","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2022.08.026_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111551","article-title":"Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases","volume":"139","author":"Bai","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jad.2022.08.026_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ene.14108","article-title":"Parkinson disease","volume":"27","author":"Balestrino","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jad.2022.08.026_bb0015","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.jad.2022.08.026_bb0020","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson's disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jad.2022.08.026_bb0025","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s11064-013-1193-y","article-title":"Celastrol from 'Thunder god Vine' protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson's disease","volume":"39","author":"Choi","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.jad.2022.08.026_bb0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.02.001","article-title":"The spectrum of \"off\" in Parkinson's disease: what have we learned over 40 years?","volume":"51","author":"Chou","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jad.2022.08.026_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2013.04.005","article-title":"Celastrol protects human neuroblastoma SH-SY5Y cells from rotenone-induced injury through induction of autophagy","volume":"63","author":"Deng","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2022.08.026_bb0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson's disease treatment: past, present, and future","volume":"127","author":"Elsworth","year":"2020","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.jad.2022.08.026_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/978-94-007-2869-1_7","article-title":"The mitochondrial pathways of apoptosis","volume":"942","author":"Estaquier","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.jad.2022.08.026_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2202-10-109","article-title":"Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a drosophila model of Parkinson's disease","volume":"10","author":"Faust","year":"2009","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.jad.2022.08.026_bb0055","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3390\/biom5042903","article-title":"Competing interactions of RNA-binding proteins, MicroRNAs, and their targets control neuronal development and function","volume":"5","author":"Gardiner","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.jad.2022.08.026_bb0060","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jad.2022.08.026_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mds.28075","article-title":"Ten unsolved questions about neuroinflammation in Parkinson's disease","volume":"36","author":"Hirsch","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2022.08.026_bb0070","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/pr.111.005678","article-title":"The pharmacology of L-DOPA-induced dyskinesia in Parkinson's disease","volume":"65","author":"Huot","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jad.2022.08.026_bb0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2022.08.026_bb0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/toxsci\/kfaa066","article-title":"Coordinated action of miR-146a and parkin gene regulate rotenone-induced neurodegeneration","volume":"176","author":"Jauhari","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jad.2022.08.026_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5483\/BMBRep.2008.41.1.011","article-title":"The role of mitochondria in apoptosis","volume":"41","author":"Jeong","year":"2008","journal-title":"BMB Rep."},{"key":"10.1016\/j.jad.2022.08.026_bb0090","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-190870","article-title":"Bergenin ameliorates MPTP-induced Parkinson's disease by activating PI3K\/Akt signaling pathway","volume":"72","author":"Ji","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jad.2022.08.026_bb0095","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/10799893.2020.1787445","article-title":"The protective effect of decoction of rehmanniae via PI3K\/Akt\/mTOR pathway in MPP(+)-induced Parkinson's disease model cells","volume":"41","author":"Jiang","year":"2021","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"10.1016\/j.jad.2022.08.026_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101664","article-title":"microRNA dysregulation in neurodegenerative diseases: a systematic review","volume":"182","author":"Ju\u017awik","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jad.2022.08.026_bb0105","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijbiomac.2019.05.061","article-title":"Development of a reliable microRNA based electrochemical genosensor for monitoring of miR-146a, as key regulatory agent of neurodegenerative disease","volume":"134","author":"Khalilzadeh","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jad.2022.08.026_bb0110","article-title":"Comparative mRNA expression of eEF1A isoforms and a PI3K\/Akt\/mTOR pathway in a cellular model of Parkinson's disease","volume":"2016","author":"Khwanraj","year":"2016","journal-title":"Parkinson's Dis."},{"key":"10.1016\/j.jad.2022.08.026_bb0115","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbadis.2016.06.001","article-title":"Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?","volume":"1862","author":"Kumar","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jad.2022.08.026_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116801","article-title":"LncRNA MALAT1 mediates proliferation of LPS treated-articular chondrocytes by targeting the miR-146a-PI3K\/Akt\/mTOR axis","volume":"254","author":"Li","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.jad.2022.08.026_bb0125","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/rej.2015.1798","article-title":"Buyang huanwu decoction vigorously rescues PC12 cells against 6-OHDA-induced neurotoxicity via Akt\/GSK3\u03b2 pathway based on serum pharmacology methodology","volume":"19","author":"Li","year":"2016","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.jad.2022.08.026_bb0130","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","article-title":"Celastrol in cancer therapy: recent developments, challenges and prospects","volume":"521","author":"Lim","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jad.2022.08.026_bb0135","first-page":"9","article-title":"Celastrol inhibits dopaminergic neuronal death of Parkinson's disease through activating mitophagy","author":"Lin","year":"2019","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"10.1016\/j.jad.2022.08.026_bb0140","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/jphp.13250","article-title":"Celastrol ameliorates endoplasmic stress-mediated apoptosis of osteoarthritis via regulating ATF-6\/CHOP signalling pathway","volume":"72","author":"Liu","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jad.2022.08.026_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114090","article-title":"Celastrol ameliorates autoimmune disorders in Trex1-deficient mice","volume":"178","author":"Liu","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jad.2022.08.026_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.648636","article-title":"PI3K\/AKT signal pathway: a target of natural products in the prevention and treatment of Alzheimer's disease and Parkinson's disease","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2022.08.026_bb0155","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jad.2022.08.026_bb0160","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.phymed.2016.10.006","article-title":"Plant-derived triterpene celastrol ameliorates oxygen glucose deprivation-induced disruption of endothelial barrier assembly via inducing tight junction proteins","volume":"23","author":"Luo","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jad.2022.08.026_bb0165","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/ijmm.2013.1375","article-title":"Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity","volume":"32","author":"Magalingam","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.jad.2022.08.026_bb0170","first-page":"23","article-title":"Design, synthesis, and neuroprotective effects of a series of pyrazolines against 6-hydroxydopamine-induced oxidative stress","author":"\u00d6zdemir","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"key":"10.1016\/j.jad.2022.08.026_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1742-2094-7-17","article-title":"Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease","volume":"7","author":"Paris","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jad.2022.08.026_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2022.08.026_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107900","article-title":"Neuroprotective effect of crocin against rotenone-induced Parkinson's disease in rats: interplay between PI3K\/Akt\/mTOR signaling pathway and enhanced expression of miRNA-7 and miRNA-221","volume":"164","author":"Salama","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2022.08.026_bb0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.bbrc.2010.03.050","article-title":"Celastrol: molecular targets of thunder god vine","volume":"394","author":"Salminen","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jad.2022.08.026_bb0195","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1381612822666151112151653","article-title":"Oxidative stress and Parkinson's disease: new hopes in treatment with herbal antioxidants","volume":"22","author":"Sarrafchi","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2022.08.026_bb0200","first-page":"473","article-title":"Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies","volume":"12","author":"Shafer","year":"1991","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.jad.2022.08.026_bb0205","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.4103\/1673-5374.300725","article-title":"Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia\/reperfusion injury","volume":"16","author":"Shao","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jad.2022.08.026_bb0210","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1515\/biol-2020-0060","article-title":"Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients","volume":"15","author":"Shu","year":"2020","journal-title":"Open Life Sci."},{"key":"10.1016\/j.jad.2022.08.026_bb0215","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-013-1034-4","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"87","author":"Sinha","year":"2013","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.jad.2022.08.026_bb0220","series-title":"MicroRNAs in Neuroinflammation: Implications in Disease Pathogenesis, Biomarker Discovery and Therapeutic Applications. Non-coding RNA","first-page":"5","author":"Slota","year":"2019"},{"key":"10.1016\/j.jad.2022.08.026_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105725","article-title":"Mechanism of action of celastrol against rheumatoid arthritis: a network pharmacology analysis","volume":"74","author":"Song","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jad.2022.08.026_bb0230","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1159\/000485488","article-title":"MiR-146a aggravates LPS-induced inflammatory injury by targeting CXCR4 in the articular chondrocytes","volume":"44","author":"Sun","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jad.2022.08.026_bb0235","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1007\/s13311-020-00929-z","article-title":"FTH1 inhibits ferroptosis through ferritinophagy in the 6-OHDA model of Parkinson's disease","volume":"17","author":"Tian","year":"2020","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jad.2022.08.026_bb0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pneurobio.2012.06.003","article-title":"Kinases and kinase signaling pathways: potential therapeutic targets in Parkinson's disease","volume":"98","author":"Wang","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jad.2022.08.026_bb0245","series-title":"Current Situation of PC12 Cell Use in Neuronal Injury Study","first-page":"61","volume":"4","author":"Wang","year":"2015"},{"key":"10.1016\/j.jad.2022.08.026_bb0250","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nm.3983","article-title":"Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes","volume":"22","author":"Wang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jad.2022.08.026_bb0255","first-page":"9","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jad.2022.08.026_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105572","article-title":"Celastrol in metabolic diseases: progress and application prospects","volume":"167","author":"Xu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jad.2022.08.026_bb0265","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10565-018-9424-2","article-title":"miR-146a down-regulation alleviates H(2)O(2)-induced cytotoxicity of PC12 cells by regulating MCL1\/JAK\/STAT pathway : miR-146a down-regulation relieves H2O2-induced PC12 cells cytotoxicity by MCL1\/JAK\/STAT","volume":"34","author":"Yang","year":"2018","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.jad.2022.08.026_bb0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ebiom.2018.09.031","article-title":"Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-\u03baB and improving mitochondrial function","volume":"36","author":"Yu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jad.2022.08.026_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/bs.irn.2017.02.004","article-title":"Effect and mechanism of chinese herbal medicine on Parkinson's disease","volume":"135","author":"Zeng","year":"2017","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.jad.2022.08.026_bb0280","article-title":"miR-146a aggravates cognitive impairment and Alzheimer disease-like pathology by triggering oxidative stress through MAPK signaling","author":"Zhan-Qiang","year":"2021","journal-title":"Neurologia (Engl. Ed.)"},{"key":"10.1016\/j.jad.2022.08.026_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102134","article-title":"The Nrf2-NLRP3-caspase-1 axis mediates the neuroprotective effects of celastrol in Parkinson's disease","volume":"47","author":"Zhang","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.jad.2022.08.026_bb0290","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jcp.25703","article-title":"Celastrol attenuates cadmium-induced neuronal apoptosis via inhibiting Ca(2+) -CaMKII-dependent Akt\/mTOR pathway","volume":"232","author":"Zhang","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jad.2022.08.026_bb0295","article-title":"Involvement of Akt\/mTOR in the neurotoxicity of rotenone-induced Parkinson's disease models","volume":"16","author":"Zhang","year":"2019","journal-title":"Int. J. Environ. Res. Public Health"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272200876X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503272200876X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:21:05Z","timestamp":1777494065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503272200876X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":59,"alternative-id":["S016503272200876X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.026","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celastrol attenuates 6-hydroxydopamine-induced neurotoxicity by regulating the miR-146a\/PI3K\/Akt\/mTOR signaling pathways in differentiated rat pheochromocytoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2022.08.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}